Supreme Cannabis

Canadian Licensed Cannabis Producer

Volume | Market Cap | Shares | PEG Ratio | EPS


*Updated October 2, 2019*

PI Finacial gives Supreme Cannabis a strong BUY rating.

Price Target: $4.50 (25x EV/EBITDA)

Potential Upside: 220% + (12 month ROI)

Learn more about Supreme Cannabis (SPRWF): WebsiteInvestor Deck

HQ: Toronto Canada
Incorporated: 1979 as Supreme Pharmaceuticals
Symbol: SPRWF (OTC)   FIRE (TSX)
Facilities: Kincardine, Ontario
Exchanges: TSX, OTC
Licenses: March 2016, 7Acres (subsidiary) received its production and sales licenses

Market Cap: $330 mil
Enterprise Value: $276 mil
Size within cannabis industry: about 14th of 200+
Size among cultivators: 13th of about 40
# of employees: NA

Markets: Strong
Primary: Near term, all Canada via wholesale markets and retail partners
Secondary: Long term, global markets where federally legal

Operations: Neutral to Good long term

Current production: 5,000 kgs/year
Future Capacity: 50,000 kgs/year production rate achieved in 2019

Distribution: Weak right now

Integration/Diversification: Weak
Vertically integrated: no
Horizontally diversified:  no

Financials: Weak right now (low)

Management: Neutral to Good

Branding: Neutral

Valuation: Neutral

Financings: Neutral to Good

Recommendation: Hold (March 31, 2019)


See Our Other Featured Companies

Profit in Your Sleep?

Take the guesswork out of investing. Use our smart algorithms to profit in cannabis and hemp.


Make Smart Investment Decisions

See our cannabis and hemp company analysis and recommendations.